Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...

Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

You should store Zepbound single-dose pens or vials in the refrigerator at 36°F to 46°F (2°C to 8°C). But if needed, you can store them unrefrigerated for up to 21 days. During that time ...

The FDA has approved medications like Zepbound and Wegovy for weight loss, which use the same active ingredient as the diabetes medications Ozempic and Mounjaro, to help patients with metabolic ...

The huge driver of this revenue generated was thanks to the company's obesity drug Zepbound, marketed as Mounjaro for the treatment of patients with Type 2 Diabetes (T2D). There were two key ...

With Zepbound at Its Core, The Naderi Center's New Initiative Addresses Male Weight Loss and Facial Rejuvenation Through ...

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

True or False: Pooled trial data showed that rheumatoid arthritis patients taking tofacitinib (Xeljanz) were less likely to ...